Skilled partners in the conduct of HIV prevention trials join COVID-19 response

IMAGE: List of clinical trial sites in the US participating in HVTN 405/HPTN 1901

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19. The study, called HVTN 405/HPTN 1901, is underway at clinical trial sites across North and South America and will describe immune responses in study participants with a history of infection with SARS-CoV-2, the virus that causes COVID-19. Read More